Caitlin Raymond/LinkedIn
Mar 27, 2026, 17:09
Caitlin Raymond: Jehovah’s Witnesses May Now Accept Autologous Blood
Caitlin Raymond, Assistant Professor of Pathology and Transfusion Medicine at University of Wisconsin-Madison, shared on LinkedIn:
”On March 20th, the Governing Body of Jehovah’s Witnesses issued new guidance: members may now accept autologous blood.
Preoperative autologous deposit – long explicitly forbidden – has moved into the personal conscience category.
This is significant. But if you work in transfusion medicine, the headlines don’t quite tell the whole story.
A few things worth knowing:
- The conscience zone was already wide before this update. Cell salvage, hemodilution, cardiopulmonary bypass, dialysis – individual decisions for years. The zone just got wider.
- Actual clinical practice has always been variable. I’ve cared for Jehovah’s Witness patients who would accept platelets (despite the contamination with allogeneic RBCs), and some who would even accept directed donations from congregation members. Jehovah’s Witness patients are whole, complex people, not policy documents.
- Autonomy without access isn’t really autonomy. PAD requires infrastructure that doesn’t exist uniformly across the 200+ countries where Jehovah’s Witnesses live and receive surgical care.
- ‘It’s now allowed’ doesn’t mean patients will feel free to accept it. Conscience operates inside a community. The conversation at the bedside still requires care, privacy, and time.
The guidance changed. The complexity didn’t.”

Stay updated with Hemostasis Today.
-
Nov 18, 2026, 14:41Factor V Deficiency: Diagnostic Challenges and the Role of Combined Factor V and VIII Deficiency
-
Nov 18, 2026, 14:29Maxime Dely: When Patient Encounters Become Life Lessons
-
Nov 18, 2026, 14:23Basanta Khatiwada: Advancing Haematology Through Research and Innovation at HAEMATOCON 2026
-
Nov 18, 2026, 14:13Alvin Katumba: Sickle Cell Disease Research Recognised With a 2026 ASH Abstract Achievement Award
-
Nov 18, 2026, 13:34Vincenzo De Angelis: Strengthening Plasma Management and Quality Control in Eastern Europe
-
Nov 18, 2026, 13:34Standardizing Bleeding Outcome Assessment in Hemophilia Clinical Trials – JTH
-
Nov 18, 2026, 13:34Nicolas Gendron: Towards Sustainable Anticoagulation
-
Nov 18, 2026, 13:33Breaking the Silence on Women and Girls with Bleeding Disorders – EHC
-
Nov 18, 2026, 13:32Maria Elisa Mancuso: Next-Generation Protein Therapies in Hemophilia